The genetic landscape of pancreatic ductal adenocarcinoma (PDAC) shows nearly ubiquitous mutations of KRAS, which are required for the initiation and progression of pancreatic ductal adenocarcinoma (PDAC) [6, 9]. The gene discussed is KRAS; the disease is pancreatic ductal adenocarcinoma.